{"id":"ethinyl-estradiol-desogestrel","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"5-15","effect":"Breakthrough bleeding"},{"rate":"2-5","effect":"Mood changes"},{"rate":"0.3-0.4","effect":"Venous thromboembolism"}]},"_chembl":null,"_dailymed":{"setId":"9bb13b85-5d54-4689-b915-50b1da3a525b","title":"DESOGESTREL AND ETHINYL ESTRADIOL KIT [APOTEX CORP.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ethinyl estradiol is a synthetic estrogen that inhibits follicle-stimulating hormone (FSH) secretion, while desogestrel is a synthetic progestin that inhibits luteinizing hormone (LH) and increases cervical mucus viscosity. Together, these mechanisms prevent ovulation, alter the endometrium, and increase cervical mucus thickness to prevent sperm penetration, providing contraceptive efficacy.","oneSentence":"Ethinyl estradiol and desogestrel work together as a combined oral contraceptive by suppressing ovulation through hormonal feedback on the hypothalamic-pituitary-ovarian axis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:11:44.135Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception (prevention of pregnancy)"},{"name":"Regulation of menstrual cycles"}]},"trialDetails":[{"nctId":"NCT07269327","phase":"PHASE1","title":"An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2025-11-24","conditions":"Fertility","enrollment":24},{"nctId":"NCT06540079","phase":"NA","title":"BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biotronik, Inc.","startDate":"2024-12-18","conditions":"Sinus Node Dysfunction, Bradycardia, Atrioventricular Block","enrollment":192},{"nctId":"NCT06852365","phase":"PHASE2","title":"Combined Oral Contraceptive Pill and Resistance Starch","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-06-10","conditions":"Metabolic Syndrome, Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT07393009","phase":"","title":"Studying Routine Patient Care With BIOTRONIK Devices That Allow a More Natural Heart Stimulation","status":"NOT_YET_RECRUITING","sponsor":"Biotronik SE & Co. KG","startDate":"2026-03-01","conditions":"Cardiac Pacing, Cardiac Pacemaker, Implantable Cardioverter Defibrillator","enrollment":1000},{"nctId":"NCT06378866","phase":"PHASE2","title":"Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-06-03","conditions":"Recurrent Castration-Sensitive Prostate Carcinoma, Recurrent Prostate Cancer, Castration-resistant Prostate Cancer","enrollment":532},{"nctId":"NCT06229366","phase":"PHASE1","title":"[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-04-03","conditions":"Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Oligometastatic Prostate Carcinoma","enrollment":142},{"nctId":"NCT07258251","phase":"PHASE4","title":"Strengthening Hepatitis B Screening, Linkage to Care and Long-Term Monitoring in Phichit Province, Thailand: A Birth Bohort Approach","status":"NOT_YET_RECRUITING","sponsor":"The Task Force for Global Health","startDate":"2026-01-01","conditions":"Chronic Hepatitis B, Hepatitis B Virus Infection","enrollment":6000},{"nctId":"NCT06620237","phase":"NA","title":"BIO|MASTER.CSP Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biotronik SE & Co. KG","startDate":"2024-10-04","conditions":"Cardiac Pacing, Artificial, Cardiac Pacemaker, Artificial, Cardiac Resynchronization Therapy Devices","enrollment":152},{"nctId":"NCT06334315","phase":"PHASE4","title":"Oral Contraceptive Pill (OCP) Pharmacogenomics","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-10-29","conditions":"Contraception, Pharmacogenomic Drug Interaction","enrollment":700},{"nctId":"NCT06318130","phase":"NA","title":"Comparison of Pacing Lead Design on Left Bundle Branch Pacing Outcomes: The LEAD_LBBP Randomized Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2023-01-01","conditions":"Pacemaker DDD","enrollment":210},{"nctId":"NCT05002738","phase":"PHASE4","title":"Desogestrel-containing COCP Pharmacokinetic Validation Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2021-09-10","conditions":"Contraception","enrollment":22},{"nctId":"NCT06148571","phase":"","title":"Left Bundle Branch Area Pacing in Heart Failure Patients With Ejection Fraction Below Normal","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2023-10-10","conditions":"Left Ventricular Ejection Fraction Less Then or Equal to 50percent","enrollment":200},{"nctId":"NCT02367846","phase":"PHASE4","title":"Assessing the Impact of Contraceptives on Bone Health Using 41Ca","status":"ACTIVE_NOT_RECRUITING","sponsor":"Penn State University","startDate":"2015-01","conditions":"Other Disorders of Bone Development and Growth","enrollment":6},{"nctId":"NCT06011252","phase":"NA","title":"Pacing Characteristics of a Conventional Bipolar","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2023-01-01","conditions":"Symptomatic Bradycardia","enrollment":150},{"nctId":"NCT04943588","phase":"","title":"Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2021-11-01","conditions":"Hepatitis C, Chronic","enrollment":25000},{"nctId":"NCT05251363","phase":"NA","title":"BIOTRONIK Conduction System Pacing With the Solia Lead","status":"COMPLETED","sponsor":"Biotronik, Inc.","startDate":"2022-12-12","conditions":"Bradycardia, Atrioventricular Block, Left Bundle-Branch Block","enrollment":194},{"nctId":"NCT06867419","phase":"","title":"Metabolic Features Effects on FAST Score in MASLD Patients","status":"RECRUITING","sponsor":"Tanta University","startDate":"2024-09-01","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease","enrollment":385},{"nctId":"NCT06386094","phase":"","title":"Cardiac Dysfunction in Patients with Fatty Liver Disease","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2023-07-15","conditions":"NAFLD, Cardiac Disease, Fatty Liver","enrollment":150},{"nctId":"NCT05350865","phase":"","title":"Thailand HDV Cohort","status":"RECRUITING","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2023-01-30","conditions":"HDV","enrollment":3152},{"nctId":"NCT03332966","phase":"","title":"Youth Experiences and Health Study","status":"RECRUITING","sponsor":"Finnish Institute for Health and Welfare","startDate":"2019-12-01","conditions":"Psychotic Disorders, Psychiatric Hospitalization, Prodromal Symptoms","enrollment":1000},{"nctId":"NCT06586983","phase":"","title":"Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2024-09-04","conditions":"Hepatitis B","enrollment":4500},{"nctId":"NCT05793502","phase":"","title":"Study on Effectiveness and Safety of LBBaP With Solia S and Selectra 3D Developed by BIOTRONIK","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2023-07-04","conditions":"Consented to Participate in the Trial and Signed an ICF, Patients With an Indication for PM Implantation or CRTP","enrollment":1000},{"nctId":"NCT04320849","phase":"","title":"Human Use Condition Study- Evaluation of Implanted Leads in Humans","status":"COMPLETED","sponsor":"Duke University","startDate":"2021-06-01","conditions":"Pacemaker Malfunction","enrollment":117},{"nctId":"NCT06049992","phase":"NA","title":"STylet-driven vs. LumenlEss Lead in Left-Bundle-Branch Pacing","status":"UNKNOWN","sponsor":"Puerta de Hierro University Hospital","startDate":"2023-09-21","conditions":"Left Bundle-Branch Pacing","enrollment":120},{"nctId":"NCT01500473","phase":"PHASE2","title":"Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome","status":"TERMINATED","sponsor":"Children's Hospital Los Angeles","startDate":"2012-02","conditions":"Congenital Central Hypoventilation Syndrome","enrollment":1},{"nctId":"NCT04573543","phase":"","title":"The Role of Immune Semaphorins in NAFLD","status":"COMPLETED","sponsor":"University Hospital for Infectious Diseases, Croatia","startDate":"2020-09-01","conditions":"Non-Alcoholic Fatty Liver Disease, Immune Response, Biomarkers","enrollment":160},{"nctId":"NCT05999331","phase":"","title":"Elevated Initial APRI Value Was Associated With SALD","status":"UNKNOWN","sponsor":"Chinese Medical Association","startDate":"2019-01-01","conditions":"Liver Dysfunction, Sepsis-associated Liver Dysfunction","enrollment":160},{"nctId":"NCT03612973","phase":"NA","title":"Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-06-01","conditions":"Chronic Hepatitis c","enrollment":80},{"nctId":"NCT03197077","phase":"PHASE3","title":"Optimisation of Follicular Recruitment in IVM Cycles","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2017-11-01","conditions":"Infertility, Female, Polycystic Ovary Syndrome","enrollment":145},{"nctId":"NCT05605158","phase":"PHASE3","title":"Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2022-11","conditions":"Non Alcoholic Steatohepatitis","enrollment":56},{"nctId":"NCT05594186","phase":"NA","title":"Nonsurgical Management of Cesarean Scar Niche Related Abnormal Uterine Bleeding","status":"COMPLETED","sponsor":"Saudi German Hospital - Madinah","startDate":"2019-03-01","conditions":"Intermenstrual Bleeding","enrollment":158},{"nctId":"NCT05503979","phase":"","title":"Elimination of Hepatitis C Virus Among Users of Substances","status":"UNKNOWN","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-11-15","conditions":"Hepatitis C in Substance Users","enrollment":1000},{"nctId":"NCT03308916","phase":"NA","title":"Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers","status":"RECRUITING","sponsor":"Maja Thiele","startDate":"2017-10-06","conditions":"Liver Diseases, Alcoholic, Fibrosis","enrollment":6500},{"nctId":"NCT05433974","phase":"NA","title":"Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk","status":"UNKNOWN","sponsor":"Centre Francois Baclesse, Luxembourg","startDate":"2022-10-01","conditions":"Radiosensitivity, Cancer, Radiation Toxicity","enrollment":200},{"nctId":"NCT00778999","phase":"PHASE4","title":"Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10-01","conditions":"Infertility","enrollment":442},{"nctId":"NCT01005056","phase":"","title":"Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-05","conditions":"Contraception","enrollment":3838},{"nctId":"NCT01291004","phase":"PHASE1","title":"A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2011-01-31","conditions":"Follicle Development, Ovarian Follicle, Follicle Count","enrollment":206},{"nctId":"NCT01388491","phase":"PHASE2","title":"A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2011-10-31","conditions":"Hemostasis, Oral Contraceptive","enrollment":293},{"nctId":"NCT00544882","phase":"PHASE3","title":"A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2007-10-31","conditions":"Healthy","enrollment":61},{"nctId":"NCT01178125","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2010-08","conditions":"Contraception, Female Contraception","enrollment":2858},{"nctId":"NCT00946192","phase":"PHASE3","title":"Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-05","conditions":"Exercise-related Amenorrhea","enrollment":121},{"nctId":"NCT01058252","phase":"","title":"Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF","status":"UNKNOWN","sponsor":"Galaxy Pharma (Pvt) Limited","startDate":"2021-05","conditions":"Primary Infertility, Secondary Infertility, Low Responders","enrollment":30},{"nctId":"NCT04380493","phase":"","title":"The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and Histology","status":"COMPLETED","sponsor":"Hospital Vall d'Hebron","startDate":"2015-05","conditions":"Elastography, Fibrosis, Liver, Pediatrics","enrollment":141},{"nctId":"NCT03353857","phase":"PHASE1","title":"Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-11-29","conditions":"Biological Availability","enrollment":68},{"nctId":"NCT02367833","phase":"PHASE4","title":"Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis","status":"COMPLETED","sponsor":"Penn State University","startDate":"2015-01","conditions":"Bone; Disorder, Development and Growth","enrollment":60},{"nctId":"NCT03212521","phase":"PHASE3","title":"Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1","status":"COMPLETED","sponsor":"AbbVie","startDate":"2017-08-07","conditions":"Hepatitis C Virus (HCV)","enrollment":230},{"nctId":"NCT03953716","phase":"PHASE4","title":"Traditional Chinese Medicine, Western Medicine and Low-level Light Therapy（LLLT） for Primary Dysmenorrhea（PD）","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-06-22","conditions":"Primary Dysmenorrhea, Traditional Chinese Medicine, Light","enrollment":480},{"nctId":"NCT02037867","phase":"","title":"Nottingham Community Liver Biomarkers Cohort","status":"RECRUITING","sponsor":"University of Nottingham","startDate":"2013-05","conditions":"Chronic Liver Disease, Alcohol Use Disorder, Type 2 Diabetes","enrollment":2000},{"nctId":"NCT00204438","phase":"NA","title":"Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2002-02","conditions":"Contraception","enrollment":45},{"nctId":"NCT01809665","phase":"","title":"ProMRI PROVEN Master Study","status":"COMPLETED","sponsor":"Biotronik SE & Co. KG","startDate":"2013-06","conditions":"Safety of MR (Magnetic Resonance) Conditional CRT-pacemakers and ICDs","enrollment":174},{"nctId":"NCT01638767","phase":"PHASE4","title":"NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles","status":"TERMINATED","sponsor":"Clinique Ovo","startDate":"2012-07","conditions":"Infertility","enrollment":7},{"nctId":"NCT01252186","phase":"PHASE2","title":"A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women","status":"COMPLETED","sponsor":"Teva Women's Health","startDate":"2010-11","conditions":"Hemostasis, Oral Contraceptive","enrollment":265},{"nctId":"NCT00624130","phase":"PHASE3","title":"Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-03","conditions":"Contraception","enrollment":453},{"nctId":"NCT01076582","phase":"PHASE3","title":"Comparative Trial in Hormone Withdrawal Associated Symptoms","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-04","conditions":"Oral Contraceptive","enrollment":592},{"nctId":"NCT01616225","phase":"PHASE2, PHASE3","title":"Growth Hormone in Poor Responders to IVF Trial","status":"TERMINATED","sponsor":"Pacific Centre for Reproductive Medicine","startDate":"2012-06","conditions":"Infertility","enrollment":60},{"nctId":"NCT01310647","phase":"PHASE2","title":"Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2011-06","conditions":"Ovarian Diseases","enrollment":66},{"nctId":"NCT00823004","phase":"PHASE1, PHASE2","title":"Antagonist/Letrozole in Poor Responders","status":"COMPLETED","sponsor":"Yazd Research & Clinical Center for Infertility","startDate":"2008-06","conditions":"Ovarian Stimulation","enrollment":120},{"nctId":"NCT01185678","phase":"","title":"Data on Oral Contraceptives Compliance in Non Stop Regimen","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-05","conditions":"Contraception","enrollment":8416},{"nctId":"NCT00826839","phase":"PHASE4","title":"Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2009-01","conditions":"Infertility","enrollment":""},{"nctId":"NCT01466673","phase":"PHASE4","title":"An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment","status":"COMPLETED","sponsor":"Janssen-Cilag Ltd.,Thailand","startDate":"2008-12","conditions":"Acne Vulgaris","enrollment":201},{"nctId":"NCT01054586","phase":"","title":"Fosamprenavir in Pts With Hepatic Impairment","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-01","conditions":"Infection, Human Immunodeficiency Virus","enrollment":167},{"nctId":"NCT00612508","phase":"NA","title":"Hormonal Contraception and Vaginal Health","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2007-05","conditions":"Contraceptive Usage, Vaginal Epithelial Disruption","enrollment":14},{"nctId":"NCT01298128","phase":"NA","title":"NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatment","status":"TERMINATED","sponsor":"University of Toronto","startDate":"2006-02","conditions":"Infertility, In-vitro Fertilization","enrollment":70},{"nctId":"NCT01588873","phase":"PHASE4","title":"Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome","status":"UNKNOWN","sponsor":"University of Oulu","startDate":"2012-04","conditions":"Adverse Effect of Oral Contraceptives, Sequela","enrollment":42},{"nctId":"NCT01482338","phase":"PHASE4","title":"Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2011-06","conditions":"Premenstrual Syndrome","enrollment":90},{"nctId":"NCT01087879","phase":"NA","title":"The Effect of Hormonal Contraceptives on Androgens and Glucose Metabolism","status":"COMPLETED","sponsor":"University of Oulu","startDate":"2007-10","conditions":"Contraception","enrollment":45},{"nctId":"NCT01384331","phase":"PHASE4","title":"New Treatments for Troublesome Bleeding in Implanon Users","status":"UNKNOWN","sponsor":"Family Planning Association New South Wales","startDate":"2011-07","conditions":"Menstrual Problem","enrollment":200},{"nctId":"NCT00236782","phase":"PHASE3","title":"A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"1997-10","conditions":"Contraception","enrollment":1517},{"nctId":"NCT01256619","phase":"PHASE2","title":"Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's Health","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2010-09","conditions":"Women With PMS","enrollment":61},{"nctId":"NCT00565240","phase":"NA","title":"Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2007-11","conditions":"Ovarian Follicle","enrollment":41},{"nctId":"NCT00185419","phase":"PHASE3","title":"A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-11","conditions":"Contraception","enrollment":842},{"nctId":"NCT00326404","phase":"PHASE3","title":"Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents","status":"UNKNOWN","sponsor":"The Hospital for Sick Children","startDate":"2006-05","conditions":"Contraception","enrollment":130},{"nctId":"NCT00675779","phase":"NA","title":"Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis","status":"UNKNOWN","sponsor":"Poznan University of Medical Sciences","startDate":"2008-04","conditions":"Endometriosis, Pain","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":22,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Apri"],"phase":"marketed","status":"active","brandName":"Ethinyl Estradiol + Desogestrel","genericName":"Ethinyl Estradiol + Desogestrel","companyName":"Massachusetts General Hospital","companyId":"massachusetts-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ethinyl estradiol and desogestrel work together as a combined oral contraceptive by suppressing ovulation through hormonal feedback on the hypothalamic-pituitary-ovarian axis. Used for Contraception (prevention of pregnancy), Regulation of menstrual cycles.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}